Skip to content
The Chat Archive
gpt-4o-mini-search-preview· OpenAI LMArena Search Arena 24K

what is the latest research regarding geroprotective drugs and compounds?

  1. User

    what is the latest research regarding geroprotective drugs and compounds?

  2. Assistant

    Recent research into geroprotective drugs and compounds has identified several promising candidates that may slow aging processes and extend healthspan. Key areas of focus include:

    1. Senolytics and Senomorphics: These compounds target senescent cells, which accumulate with age and contribute to various age-related diseases.

    • Senolytics: These agents selectively induce death in senescent cells. Notable examples include:

      • Fisetin: Activates caspases-7, -8, and -9, leading to cell death.
      • Quercetin: Inhibits PI3K and other kinases, promoting apoptosis.
      • Dasatinib: A tyrosine kinase inhibitor effective in combination with quercetin.
      • FOXO4-DRI: A peptide that disrupts the interaction between FOXO4 and p53, inducing apoptosis in senescent cells.
    • Senomorphics: These compounds modulate the senescence-associated secretory phenotype (SASP) without affecting cell viability. Examples include:

      • Rapamycin: An mTOR inhibitor that reduces SASP factors.
      • Ruxolitinib: A JAK inhibitor that decreases pro-inflammatory cytokines.
      • Trichostatin A and Vorinostat: HDAC inhibitors that can alter gene expression associated with senescence.

    These agents have shown efficacy in animal models, reducing senescence markers, restoring tissue homeostasis, and extending lifespan[1].

    2. Polyphenols: Dietary polyphenols have been linked to various health benefits and are considered potential geroprotectors.

    • Chlorogenic Acid, Quercetin, Epicatechin, Genistein, Resveratrol, and Curcumin: These compounds have demonstrated the ability to increase lifespan and improve biomarkers of aging in animal models. They act through mechanisms such as hormesis, maintenance of redox homeostasis, epigenetic regulation, response to cellular damage, metabolic control, and anti-inflammatory and senolytic activity. Epidemiological and clinical studies suggest that certain polyphenols may help prevent and treat various diseases, including cancer, metabolic disorders, and cardiovascular conditions in humans[2].

    3. Alzheimer's Disease Drug Candidates: Compounds originally developed for Alzheimer's disease are being investigated for their geroprotective effects.

    • J147 and CMS121: These compounds have been shown to extend lifespan in Drosophila melanogaster. In studies, J147 increased survival by 12.8%, and CMS121 increased survival by 8.46%. Additionally, both compounds improved markers for brain and kidney health in aged mice, suggesting potential benefits in age-related organ decline[3].

    While these findings are promising, further research, including clinical trials, is necessary to fully understand the efficacy and safety of these compounds in humans.

Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.